AbbVie
ABBV
#29
Rank
$326.96 B
Marketcap
$185.16
Share price
1.64%
Change (1 day)
30.49%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2024 (TTM): $7.53 B

According to AbbVie's latest financial reports the company's current earnings (TTM) are $7.53 B. In 2023 the company made an earning of $6.25 B a decrease over its 2022 earnings that were of $13.47 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $7.53 B20.48%
2023 $6.25 B-53.62%
2022 $13.47 B3.76%
2021 $12.98 B282.25%
2020 $3.39 B-59.67%
2019 $8.42 B62.13%
2018 $5.19 B-32.74%
2017 $7.72 B-1.99%
2016 $7.88 B18.65%
2015 $6.64 B180.5%
2014 $2.36 B-55.57%
2013 $5.33 B-6.86%
2012 $5.72 B56.05%
2011 $3.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$0.89 B-88.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.85 B-177.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.56 B 0.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.34 B-42.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.07 B-85.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.32 B-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.88 B-8.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
$9.08 B 20.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.47 B-93.70%๐Ÿ‡บ๐Ÿ‡ธ USA